Ophthalmology Times - Ophthalmology news, articles, and events
Oct 5, 2024 · This Week in Ophthalmology: Week of October 5, 2024. World Sight Day 2024: Experts weigh-in on potential impact of AI in diagnostics and screening. Advancing CVI research: NEI initiative and multidisciplinary collaboration. Prevent Blindness officials discuss National Academies of Sciences, Engineering, and Medicine's report on myopia.
Physicians sort out pros and cons of several new IOLs on the market
Nov 12, 2021 · The 2 newest multifocal IOLs—AcrySof IQ PanOptix (Alcon) and Tecnis Synergy (Johnson + Johnson Vision)—almost guarantee a broader range of vision than EDoF IOLs but not the avoidance of photic phenomena, Sood said. The PanOptix is a trifocal lens with negative spherical aberration on its anterior surface that has diffractive rings in the ...
Alcon reveals final data from Vivity Registry Study which …
Sep 13, 2023 · Alcon has announced final data from its Vivity Registry Study, which monitored real-world patient experiences for up to 12 months post cataract surgery with implantation of either AcrySof IQ Vivity or AcrySof IQ Vivity Toric presbyopia-correcting intraocular lens (PCIOL).
Study suggests potential link between semaglutide and risk of non ...
Jul 9, 2024 · Boston researchers led by first author Jimena Tatiana Hathaway, MD, MPH, reported that there is a potential risk of the development of non-arteritic ischemic optic neuropathy (NAION) 1 associated with prescriptions for semaglutide (Wegovy, Ozempic, Novo Nordisk). Prescriptions with semaglutide are FDA approved to treat obesity and type 2 diabetes, respectively.
Fluorometholone acetate: More benefit than meets the eye
Dec 11, 2019 · The ability of a drug to penetrate into the ocular tissues is key to controlling inflammation. “All fluorometholones are not the same,” said Beeran Meghpara, MD, and with good reason.Fluorometholone is the active steroid in formulations used to treat ocular inflammation- however, it is what doesn’t meet the eye that makes the difference, i.e., the vehicle.
nAMD patients successfully switch from aflibercept to biosimilar ...
Sep 13, 2024 · The study, 1 published in Clinical Ophthalmology, was a multicenter observational study on patients over the age of 50 with nAMD. Patients were shifted from intravitreal aflibercept to biosimilar ranibizumab due to financial constraints. In total, 29 eyes were analyzed, 12 male and 17 female, with a mean age of 72.55 ±6.43 years.
Combination eye drop manages inflammation and infection after …
Apr 23, 2022 · Blake K. Williamson, MD, MPH, MS, and coauthor Urvi Patel, BSc, presented an e-poster at the American Society of Cataract and Refractive Surgery’s 2022 annual meeting in Washington, D.C., on the efficacy of a combination eye drop comprised of an antibiotic, anti-inflammatory and lubricant as part of a postoperative …
Ophthalmologists: Castor oil shouldn’t be rubbed in the eyes, no …
Aug 8, 2023 · Ophthalmologists are issuing a warning not to use castor oil as a way to treat vision problems amid claims circulating on TikTok. In its heyday, castor oil was considered a jack-of-all-trades home remedy, used as a laxative, a moisturizer and even as a chest rub to ease lung congestion. Now, it is making a comeback as some influencers on TikTok ...
Keeping an eye on CME: How to treat, when to refer
Apr 22, 2022 · Use of topical steroid monotherapy or a steroid plus an NSAID have been beneficial but the data also show mixed results, she reported. In patients with acute pseudophakic CME, Dr. Weng prefers using a topical NSAID and a steroid such as bromfenac 0.07% dosed once daily and prednisolone acetate 1% 4 times daily, although many other effective ...
Myths and misconceptions about autologous serum for dry eye
Jun 22, 2020 · Special to Ophthalmology Times® Autologous serum eye drops (ASEDs) have become a mainstay of therapy for certain categories of patients with dry eye and those with underlying immunologic disease or poor epithelial healing.. The logistics of prescribing ASEDs have changed dramatically in the past few years, making their use far more convenient for patients and physicians alike.